Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Spironolactone for EGFR Inhibitor-Induced Rash
NCT01867294Phase 2Completed
- Sponsor
- Academic and Community Cancer Research United
- Start
- Aug 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of spironolactone in drug eruption, sponsored by Academic and Community Cancer Research United. Started Aug 2012; status: completed.
02
Drugs
spironolactone
03
Conditions
drug eruption
Beyond the preview
Go deeper on NCT01867294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01867294.